作者
AJ Ullmann, M Akova, R Herbrecht, C Viscoli, MC Arendrup, SEVTAP Arikan‐Akdagli, Matteo Bassetti, J Bille, T Calandra, E Castagnola, OA Cornely, J Peter Donnelly, J Garbino, AH Groll, WW Hope, HE Jensen, BJ Kullberg, C Lass‐Flörl, O Lortholary, Wouter Meersseman, G Petrikkos, MD Richardson, E Roilides, PE Verweij, M Cuenca‐Estrella, ESCMID Fungal Infection Study Group (EFISG)
发表日期
2012/12
期刊
Clinical Microbiology and Infection
卷号
18
页码范围
53-67
出版商
Blackwell Publishing Ltd
简介
Clin Microbiol Infect 2012; 18 (Suppl. 7): 53–67
Abstract
Fungal diseases still play a major role in morbidity and mortality in patients with haematological malignancies, including those undergoing haematopoietic stem cell transplantation. Although Aspergillus and other filamentous fungal diseases remain a major concern, Candida infections are still a major cause of mortality. This part of the ESCMID guidelines focuses on this patient population and reviews pertaining to prophylaxis, empirical/pre‐emptive and targeted therapy of Candida diseases. Anti‐Candida prophylaxis is only recommended for patients receiving allogeneic stem cell transplantation. The authors recognize that the recommendations would have most likely been different if the purpose would have been prevention of all fungal infections (e.g. aspergillosis). In targeted treatment of candidaemia, recommendations for treatment are available for all …
学术搜索中的文章
AJ Ullmann, M Akova, R Herbrecht, C Viscoli… - Clinical Microbiology and Infection, 2012